Cite
Immune system and intestinal microbiota determine efficacy of androgen deprivation therapy against prostate cancer
MLA
Safae Terrisse, et al. “Immune System and Intestinal Microbiota Determine Efficacy of Androgen Deprivation Therapy against Prostate Cancer.” Journal for ImmunoTherapy of Cancer, vol. 10, Mar. 2022, p. e004191. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8078224a9503d196b359fd0d37288ed2&authtype=sso&custid=ns315887.
APA
Safae Terrisse, Anne-Gaelle Goubet, Kousuke Ueda, Andrew Maltez Thomas, Valentin Quiniou, Cassandra Thelemaque, Garett Dunsmore, Emmanuel Clave, Melissa Gamat-Huber, Satoru Yonekura, Gladys Ferrere, Conrad Rauber, Hang Phuong Pham, Jean-Eudes Fahrner, Eugenie Pizzato, Pierre Ly, Marine Fidelle, Marine Mazzenga, Carolina Alves Costa Silva, … Laurence Zitvogel. (2022). Immune system and intestinal microbiota determine efficacy of androgen deprivation therapy against prostate cancer. Journal for ImmunoTherapy of Cancer, 10, e004191.
Chicago
Safae Terrisse, Anne-Gaelle Goubet, Kousuke Ueda, Andrew Maltez Thomas, Valentin Quiniou, Cassandra Thelemaque, Garett Dunsmore, et al. 2022. “Immune System and Intestinal Microbiota Determine Efficacy of Androgen Deprivation Therapy against Prostate Cancer.” Journal for ImmunoTherapy of Cancer 10 (March): e004191. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8078224a9503d196b359fd0d37288ed2&authtype=sso&custid=ns315887.